Rchr
J-GLOBAL ID：202001019278905186
Update date: Oct. 19, 2024
Nomura Motoo
ノムラ モトオ | Nomura Motoo
Affiliation and department：
Research theme for competitive and other funds (2)：
- 2019 - 2021 抗PD-1抗体の効果予測バイオマーカーの確立
- 2009 - 2011 Does Vertebroplasty affect radiation dose distribution?: Comparison of spatial dose distributions in a cement-injected vertebra as calculated by treatment planning system and actual spatial dose distribution
Papers (69)：
-
Motoo Nomura, Toshifumi Yamaguchi, Keisho Chin, Shinji Hato, Ken Kato, Eishi Baba, Hisahiro Matsubara, Hidenori Mukaida, Takako Yoshii, Masahiro Tsuda, et al. Phase II Trial of Adjuvant S-1 Following Neoadjuvant Chemotherapy and Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: The PIECE Trial. Annals of surgical oncology. 2024
-
Takayuki Tsuji, Satoru Matsuda, Yuta Sato, Koji Tanaka, Ken Sasaki, Masaya Watanabe, Yoichi Hamai, Motomi Nasu, Zenichiro Saze, Yuichiro Nakashima, et al. ASO Author Reflections: Can Conversion Therapy be an Option for Advanced Esophageal Cancer with Distant Metastases?. Annals of surgical oncology. 2024
-
Takayuki Tsuji, Satoru Matsuda, Yuta Sato, Koji Tanaka, Ken Sasaki, Masaya Watanabe, Yoichi Hamai, Motomi Nasu, Zenichiro Saze, Yuichiro Nakashima, et al. Safety and Efficacy of Conversion Therapy After Systemic Chemotherapy in Advanced Esophageal Cancer with Distant Metastases: A Multicenter Retrospective Observational Study. Annals of surgical oncology. 2024
-
Chikatoshi Katada, Tetsuji Yokoyama, Akinori Watanabe, Hiroki Hara, Takako Yoshii, Hirofumi Fujii, Hironori Yamaguchi, Takako Eguchi Nakajima, Naoki Izawa, Takayuki Ando, et al. Optimizing Organ Preservation Strategies through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results from the CROC Multi-Institutional Phase II Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 2024
-
Keita Sasaki, Motoo Nomura, Ken Kato, Katsuyuki Sakanaka, Yoshinori Ito, Tomohiro Kadota, Ryunosuke Machida, Tomoko Kataoka, Keiko Minashi, Yasuhiro Tsubosa, et al. A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904). Japanese journal of clinical oncology. 2024. 54. 1. 103-107
ｍore...
MISC (164)：
-
加地紫苑, 加地紫苑, 白柏魅怜, 村上孝作, 横井茉里, 古川えりか, 吉田亜希子, 中村友紀, 田澤晃太朗, 池見泰明, et al. 免疫介在性炎症性疾患(IMID)合併がん患者における免疫チェックポイント阻害薬の使用と免疫関連副作用(irAE)の検討. 日本臨床免疫学会総会プログラム・抄録集. 2023. 51st
-
Mayumi Takata, Motoo Nomura, Kentaro Yamamura, Manabu Muto, Takaya Komori, Atsushi Otsuka, Kenji Kabashima. Autoimmune polyendocrine syndrome type 3, characterized by autoimmune thyroid disease, type 1 diabetes mellitus, and isolated ACTH deficiency, developed during adjuvant nivolumab treatment. Asia-Pacific Journal of Clinical Oncology. 2021
-
Motoo Nomura, Katsuyuki Sakanaka, Ken Kato, Tomohiro Kadota, Yoshinori Ito, Ryunosuke Machida, Keita Sasaki, Tomoko Kataoka, Yasumasa Nishimura, Yuko Kitagawa. A randomized controlled phase III trial of comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer:JCOG1904/ARMADILLO study. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 3
-
Tomohiro Kondo, Quy Pham Nguyen, Junichi Matsubara, Keita Fukuyama, Motoo Nomura, Taro Funakoshi, Mari Funakoshi, Hitomi Sakamoto, Kanami Ashida, Kumi Mukai, et al. Comprehensive genomic profiling for chemotherapy-naive advanced gastrointestinal malignancies. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 4
-
玉置 将司, 堀松 高博, 横山 顕礼, 天沼 裕介, 宮本 心一, 山田 敦, 野村 基雄, 船越 真木子, 松本 繁巳, 大橋 真也, et al. 多発ヨード不染帯を有する食道早期癌内視鏡切除後患者に対するTS-1療法の食道内多発癌抑制効果に関する検討. 日本消化管学会雑誌. 2020. 4. Suppl. 303-303
ｍore...
Return to Previous Page
